Self-management for People with Epilepsy
NCT04705441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2025-02-03
Summary
SMART is a program for adult individuals with sub-optimally controlled epilepsy. It involves educational and behavioral interventions intended to enhance epilepsy self-management.
The group sessions are conducted remotely over the teleconferencing application, Zoom. These sessions are held over an 8 week time period and are co-lead by a trained nurse educator and a trained peer educator. The peer educator is someone with epilepsy and a history of NHEs. Educators use a written curriculum delivered online, and the interactive sessions last 60-90 minutes. Groups are limited to about 6 -12 adult participants.
After the group sessions are done, individuals have 3 telephone maintenance sessions with the nurse educator once a month for the first 3 months after the group sessions end spaced approximately 4 weeks apart.
SMART is intended for adults with epilepsy, especially those who belong to disadvantaged sub groups such as rural populations, veterans with epilepsy and those who are underinsured. People with epilepsy who belong to disadvantaged sub-groups are more likely to have poor outcomes and often end up using expensive crisis-oriented care, and thus potentially might benefit the most from self-management programs if they can be actively engaged.
Conditions
Interventions
- BEHAVIORAL
-
SMART 2
Participants receiving the SMART intervention will participate in 8 group-format 45-60 minute sessions (up to 10 participants per group), which will be collaboratively delivered over Zoom by a Nurse Educator and a Peer Educator with epilepsy. Telephone call-in and supplemental printed materials will be available for those who do not have internet access. The initial group session portion of SMART will be completed over 10-12 weeks. Educational components address the challenges imposed by epilepsy and comorbidity, as well as problem-identification and goal-setting, while Peer Educators and the group format address adherence, social support/social isolation, and self-efficacy. Following group sessions, participants will have 3 brief (no more than 15 minutes) monthly web-based or telephone maintenance sessions conducted by the Nurse Educator. Telephone sessions will address on-going issues of epilepsy self-management, including treatment adherence.
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
Mark A. Granner
lead OTHER
Principal Investigators
-
Martha Sajatovic, MD · Case Western Reserve University
-
Mark Granner, MD · University of Iowa
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-19
- Primary Completion
- 2024-12-03
- Completion
- 2024-12-03
Countries
- United States
Study Locations
More Related Trials
-
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
NCT00232596 ·Status: COMPLETED ·Phase: PHASE3
-
Enhancing Medical Compliance and Health-related Quality of Life of Patients With Epilepsy
NCT02547389 ·Status: COMPLETED ·Phase: NA
-
Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy
NCT00522522 ·Status: COMPLETED
-
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
NCT00235755 ·Status: COMPLETED ·Phase: PHASE3
-
Human Epilepsy Project 3
NCT05374928 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
NCT03283371 ·Status: COMPLETED ·Phase: PHASE2
-
Enhancing Antiepileptic Drug Adherence
NCT02165306 ·Status: COMPLETED ·Phase: NA
-
Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications
NCT05321641 ·Status: UNKNOWN ·Phase: NA
-
Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
NCT01227902 ·Status: COMPLETED ·Phase: PHASE3
-
A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
NCT01393743 ·Status: COMPLETED ·Phase: PHASE3
-
Perampanel in Seizure Patients With Primary Glial Brain Tumors
NCT02363933 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures
NCT01721317 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures
NCT02687711 ·Status: COMPLETED
-
Stress and Seizures - Can a Brief Self-help Book Help?
NCT02465047 ·Status: COMPLETED ·Phase: NA
-
Human Epilepsy Project 2: Resistant Focal Seizures Study
NCT03531008 ·Status: COMPLETED
-
Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy
NCT00957047 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Youth Epilepsy and Successful Self-Management Intervention
NCT03639233 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
NCT03288129 ·Status: COMPLETED ·Phase: PHASE4
-
Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy
NCT01587339 ·Status: COMPLETED
-
Precision Medicine in the Treatment of Epilepsy
NCT05450822 ·Status: RECRUITING
-
Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
NCT00310375 ·Status: COMPLETED ·Phase: PHASE3
-
Goals for Epilepsy Clinic Visits Trial
NCT05928598 ·Status: RECRUITING ·Phase: NA
-
Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
NCT06608966 ·Status: RECRUITING ·Phase: NA